These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6836324)

  • 41. Expression of vascular endothelial growth factor (VEGF-A) in rat mandibular salivary gland during paraneoplastic process and treatment with cyclophosphamide and melatonin.
    Ovsyanko EV; Kulishenko AO; Lushnikova EL; Vinogradov AS; Zhurakovskii IP; Pustovetova MG; Ovsyanko YU
    Bull Exp Biol Med; 2015 Mar; 158(5):676-80. PubMed ID: 25778658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of Dunning asc itic leukemia and Walker 256 carcinosarcoma with cis-diamminedichloroplatinum (NSC-119875).
    Kociba RJ; Sleight SD; Rosenberg B
    Cancer Chemother Rep; 1970 Oct; 54(5):325-8. PubMed ID: 5514621
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies on the effect of tumor type and route of administration on the antitumor activity of the amino acid mimosine (NSC-69188).
    DeWys WD; Hall TC
    Cancer Chemother Rep; 1973 Feb; 57(1):41-9. PubMed ID: 4704102
    [No Abstract]   [Full Text] [Related]  

  • 44. [Experimental toxicologic and therapeutic studies on the activity of the CMF(cyclophosphamide-methotrexate-5-fluorouracil) scheme versus the VMF(vincristine-methotrexate-5-fluorouracil) scheme].
    Berger MR; Habs M; Schmähl D
    Arch Geschwulstforsch; 1984; 54(4):263-78. PubMed ID: 6548622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic efficacy of cyclophosphamide as a function of inhibition of its metabolism.
    Sladek NE
    Cancer Res; 1972 Sep; 32(9):1848-54. PubMed ID: 4641276
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of oral oxyphenbutazone (Tandearil) on tumor growth and the level of the seromucoid fraction in rats bearing Walker 256 carcinoma.
    Macbeth RA; Fischer JD
    Can J Physiol Pharmacol; 1971 Dec; 49(12):1071-7. PubMed ID: 5142312
    [No Abstract]   [Full Text] [Related]  

  • 47. Inhibition by hydrazine sulfate and various hydrazides, of in vivo growth of Walker 256 intramuscular carcinoma, B-16 melanoma, Murphy-Sturm lymphosarcoma and L-1210 solid leukemia.
    Gold J
    Oncology; 1973; 27(1):69-80. PubMed ID: 4739164
    [No Abstract]   [Full Text] [Related]  

  • 48. Different sensitivity of two Walker 256 carcinoma lines to cyclophosphamide: correlation with drug distribution, biotransformation and macromolecule binding.
    Donelli MG; Guaitani A; Torti L; Damia G; Corti F; Bianchi M; Tortoreto M; Pantarotto C; Bartosek I
    Oncology; 1986; 43(4):257-63. PubMed ID: 3725287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prophylactic intravesical instillation of epinephrine prevents cyclophosphamide-induced hemorrhagic cystitis in rats.
    Chow YC; Yang S; Huang CJ; Tzen CY; Su YH; Wang PS
    Exp Biol Med (Maywood); 2007 Apr; 232(4):565-70. PubMed ID: 17392493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Experimental animal studies on the regional perfusion of tumors of the extremities].
    Brock N; Niekamp T
    Arzneimittelforschung; 1968 Jan; 18(1):1-7. PubMed ID: 5754938
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation of effects of chitosan in preventing hemorrhagic cystitis in rats induced by cyclophosphamide.
    Okamura T; Masui T; St John MK; Cohen SM; Taylor RJ
    Hinyokika Kiyo; 1995 Apr; 41(4):289-96. PubMed ID: 7785558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Studies with Proresid (SP-I) in various innoculation tumors].
    Osswald H; Schmähl D
    Med Klin; 1966 Apr; 61(17):681-4. PubMed ID: 5995181
    [No Abstract]   [Full Text] [Related]  

  • 53. Potentials for the use of heparin in combination with radiation therapy, Experience with ascitic Walker 256 carcinosarcoma in weanling rats.
    Torpie RJ
    J Med; 1974; 5(1):133-48. PubMed ID: 4524856
    [No Abstract]   [Full Text] [Related]  

  • 54. Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.
    Gold J
    Cancer Biochem Biophys; 1978; 3(1):41-5. PubMed ID: 552898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Ultrastructural changes in cells of the original tumors, metastases and stroma of rat walker-256 carcinosarcoma treated with a heparin complex with urea].
    Kolomina SM; Chentsov IuS; Pogodina LS; Kudriashov BA; Kalishevskaia TM
    Tsitol Genet; 1979; 13(1):8-15. PubMed ID: 442204
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparative studies on the effectiveness of various cytostatics and radiation therapy of experimental tumors in a sample experiment with special regard to telegammatherapy with cobalt60. Survival experiments and cures after the administration of cyclophosphamide ester, triethyleneiminebenzoquinone and radiation separately and in various combinations with Yoshida sarcoma, carcinoma Walker and Jensen sarcoma in albino rats].
    Schneider R
    Strahlentherapie Sonderb; 1965; 61():367-72. PubMed ID: 5827135
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of uroprotective efficacy of amifostine against cyclophosphamide induced hemorrhagic cystitis.
    Srivastava A; Nair SC; Srivastava VM; Balamurugan AN; Jeyaseelan L; Chandy M; Gunasekaran S
    Bone Marrow Transplant; 1999 Mar; 23(5):463-7. PubMed ID: 10100560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Kinetics of the change in free radical content during the development of Walker carcinosarcoma and the action of Thio-TEPA].
    Saprin AN; Minenkova EA; Nagler LG; Kaznacheev IuS; Krugliak SA; Krugliakova KE; Emanuél' NM
    Biofizika; 1967; 12(6):1099-103. PubMed ID: 4318224
    [No Abstract]   [Full Text] [Related]  

  • 59. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
    Keller HJ; Keppler B; Schmähl D
    Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Keratinocyte growth factor ameliorates cyclophosphamide-induced ulcerative hemorrhagic cystitis.
    Ulich TR; Whitcomb L; Tang W; O'Conner Tressel P; Tarpley J; Yi ES; Lacey D
    Cancer Res; 1997 Feb; 57(3):472-5. PubMed ID: 9012476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.